OPTIMIZATION OF PATIENTS MANAGEMENT IN MYOCARDIAL INFARCTION COMORBIDITY WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Aim. To investigate on the efficacy of thiotriazoline (TTZ) in complex management of acute myocardial infarction (AMI) patients with hepatic steatosis.Material and methods. Totally, 32 left ventricle AMI patients included, comorbid with non-alcoholic fatty liver disease. Assessment of electrical act...
| Published in: | Российский кардиологический журнал |
|---|---|
| Main Author: | I. E. Belaya |
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2017-12-01
|
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1061 |
Similar Items
SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)
by: I. E. Belaya, et al.
Published: (2015-12-01)
MODERN ELECTROCARDIOGRAPHIC METHODS OF ESTIMATION OF CORONARY REPERFUSION AT THROMBOLYSIS IN ACUTE PERIOD OF MYOCARDIAL INFARCTION
by: I. Ye. Belaya
Published: (2014-04-01)
by: I. Ye. Belaya
Published: (2014-04-01)
VECTOR ELECTROCARDIOGRAPHY IN THE DIAGNOSTICS OF FOCAL CHANGES IN THE MYOCARDIUM
by: I. Ye. Belaya, et al.
Published: (2015-04-01)
by: I. Ye. Belaya, et al.
Published: (2015-04-01)
THE MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: I. E. Belaya
Published: (2014-07-01)
by: I. E. Belaya
Published: (2014-07-01)
Classification of Cardiac Signals in Order to Diagnose Myocardial Infarction based on Extraction of Morphological Features from Spatio-Temporal Patterns of Vectorcardiogram Signals
by: Nastaran Jafari-Hafshejani, et al.
Published: (2020-01-01)
by: Nastaran Jafari-Hafshejani, et al.
Published: (2020-01-01)
ST-segment elevation myocardial infarction in the presence of metabolic-associated fatty liver disease
by: V. A. Tretyakova, et al.
Published: (2023-12-01)
by: V. A. Tretyakova, et al.
Published: (2023-12-01)
Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)
by: N. R. Matkovska, et al.
Published: (2020-04-01)
Automatic Classification of Myocardial Infarction Using Spline Representation of Single-Lead Derived Vectorcardiography
by: Yu-Hung Chuang, et al.
Published: (2020-12-01)
by: Yu-Hung Chuang, et al.
Published: (2020-12-01)
Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)
by: N. Matkovska
Published: (2020-06-01)
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)
by: Akash Roy, et al.
Published: (2024-09-01)
Meta-Analysis of Non-Alcoholic Fatty Liver Disease and Electromechanical Reconstruction of Myocardium
by: V. A Tretyakova, et al.
Published: (2022-02-01)
by: V. A Tretyakova, et al.
Published: (2022-02-01)
Selected transformation methods and their comparison for VCG leads deriving
by: Jaroslav Vondrak, et al.
Published: (2022-05-01)
by: Jaroslav Vondrak, et al.
Published: (2022-05-01)
Nutritional Management in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Sepideh Mahboobi, et al.
Published: (2015-07-01)
by: Sepideh Mahboobi, et al.
Published: (2015-07-01)
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
by: Hyunwoo Oh, et al.
Published: (2023-02-01)
by: Hyunwoo Oh, et al.
Published: (2023-02-01)
Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01)
by: Marium Ahmed, et al.
Published: (2024-04-01)
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)
by: Daryl Ramai, et al.
Published: (2021-12-01)
Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)
by: N. R. Matkovska, et al.
Published: (2020-06-01)
The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)
Cross Subject Myocardial Infarction Detection From Vectorcardiogram Signals Using Binary Harry Hawks Feature Selection and Ensemble Classifiers
by: M. Krishna Chaitanya, et al.
Published: (2024-01-01)
by: M. Krishna Chaitanya, et al.
Published: (2024-01-01)
Association of Lipid Profile and Liver Parameters with Different Grades of Non-alcoholic Fatty Liver Disease
by: Drutpal Baghel, et al.
Published: (2023-03-01)
by: Drutpal Baghel, et al.
Published: (2023-03-01)
Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)
Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
by: Alexandra Jichitu, et al.
Published: (2021-04-01)
by: Alexandra Jichitu, et al.
Published: (2021-04-01)
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
by: Teodora Biciusca, et al.
Published: (2023-10-01)
by: Teodora Biciusca, et al.
Published: (2023-10-01)
Curcumin and non-alcoholic fatty liver disease
by: Nasrin Sharifi, et al.
Published: (2024-06-01)
by: Nasrin Sharifi, et al.
Published: (2024-06-01)
Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
by: Divyavani Gowda, et al.
Published: (2023-11-01)
by: Divyavani Gowda, et al.
Published: (2023-11-01)
Lysophospholipid metabolism and signalling in non-alcoholic fatty liver disease
by: Charalambos Papadopoulos, et al.
Published: (2022-02-01)
by: Charalambos Papadopoulos, et al.
Published: (2022-02-01)
Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
by: Mehdi Foroughi, et al.
Published: (2016-01-01)
by: Mehdi Foroughi, et al.
Published: (2016-01-01)
Non-alcoholic fatty liver disease: time for changes
by: T.I. Yefimenko, et al.
Published: (2021-06-01)
by: T.I. Yefimenko, et al.
Published: (2021-06-01)
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
by: Tatiana Y. Demidova, et al.
Published: (2023-11-01)
by: Tatiana Y. Demidova, et al.
Published: (2023-11-01)
Mean Platelet Volume in Patients with Non-Alcoholic Fatty Liver Disease
by: Miryala Srikar, et al.
Published: (2021-07-01)
by: Miryala Srikar, et al.
Published: (2021-07-01)
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)
by: Ye Eun Cho, et al.
Published: (2023-03-01)
Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)
Functional condition of vascular endothelium in patients with coronary heart disease in combination with non-alcoholic fatty liver disease, depending on weight and influence of statin therapy
by: O. V. Kuryata, et al.
Published: (2015-02-01)
by: O. V. Kuryata, et al.
Published: (2015-02-01)
Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
by: Ying-Chin Lin, et al.
Published: (2011-04-01)
by: Ying-Chin Lin, et al.
Published: (2011-04-01)
Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
by: Saira Rafaqat, et al.
Published: (2024-03-01)
by: Saira Rafaqat, et al.
Published: (2024-03-01)
Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)
by: Seul Ki Han, et al.
Published: (2023-02-01)
A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
by: Jiang YJ, et al.
Published: (2024-04-01)
by: Jiang YJ, et al.
Published: (2024-04-01)
FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus
by: Wenfei Duan, et al.
Published: (2023-10-01)
by: Wenfei Duan, et al.
Published: (2023-10-01)
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
by: Ju Hyun Shim
Published: (2020-04-01)
by: Ju Hyun Shim
Published: (2020-04-01)
Similar Items
-
SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01) -
MODERN ELECTROCARDIOGRAPHIC METHODS OF ESTIMATION OF CORONARY REPERFUSION AT THROMBOLYSIS IN ACUTE PERIOD OF MYOCARDIAL INFARCTION
by: I. Ye. Belaya
Published: (2014-04-01) -
VECTOR ELECTROCARDIOGRAPHY IN THE DIAGNOSTICS OF FOCAL CHANGES IN THE MYOCARDIUM
by: I. Ye. Belaya, et al.
Published: (2015-04-01) -
THE MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: I. E. Belaya
Published: (2014-07-01) -
Classification of Cardiac Signals in Order to Diagnose Myocardial Infarction based on Extraction of Morphological Features from Spatio-Temporal Patterns of Vectorcardiogram Signals
by: Nastaran Jafari-Hafshejani, et al.
Published: (2020-01-01)
